SAM
FATE icon

Sectoral Asset Management’s Fate Therapeutics FATE Stock Holding History

Sectoral Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-183,000
Closed -$1.85M – 123
2022
Q4 		$1.85M Hold
183,000
– – 0.36% 81
2022
Q3 		$4.1M Hold
183,000
– – 0.81% 56
2022
Q2 		$4.54M Sell
183,000
-10,160
-5% -$280K 0.91% 47
2022
Q1 		$7.49M Hold
193,160
– – 1.33% 30
2021
Q4 		$11.3M Hold
193,160
– – 1.7% 19
2021
Q3 		$11.4M Buy
193,160
+46,160
+31% +$3.62M 0.95% 38
2021
Q2 		$12.8M Buy
147,000
+4,500
+3% +$363K 1.03% 39
2021
Q1 		$11.7M Buy
142,500
+43,500
+44% +$4.17M 0.89% 46
2020
Q4 		$9M Buy
+99,000
New +$6.15M 0.63% 55

Other funds holding FATE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Sectoral Asset Management's FATE Position: Q1 2023 in Review

Sectoral Asset Management sold out of Fate Therapeutics (FATE) in Q1 2023, closing a stake of 183,000 shares — an estimated $1.85M sold.

Sectoral Asset Management first reported a position in FATE in Q4 2020 and held it in 9 quarters. The position peaked at $12.8M in Q2 2021. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.

  • Sectoral Asset Management reported no remaining Fate Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Sectoral Asset Management sold 183,000 Fate Therapeutics shares in Q1 2023, an estimated $1.85M.
  • Sectoral Asset Management first reported a position in Fate Therapeutics in Q4 2020 and held it in 9 quarters.
  • Sectoral Asset Management's Fate Therapeutics position peaked at $12.8M in Q2 2021.
  • 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.

Based on Sectoral Asset Management's 13F filing for Q1 2023, filed 12 May 2023.